What is the optimal angiotensin-converting enzyme inhibitor dose in heart failure?

Congestive heart failure (Greenwich, Conn.)

Volumn 12, Issue 4, 2006, Pages 213-218

  Thomas, Sabu ^a   Geltman, Edward ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CONGESTIVE HEART FAILURE; DRUG EFFECT; EXERCISE TOLERANCE; HUMAN; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; EXERCISE TOLERANCE; HEART FAILURE, CONGESTIVE; HUMANS; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 33750102242     PISSN: 15275299     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2006.05367.x     Document Type: Review

References (42)